HIV 1 News and Research

RSS

ECDC and WHO release latest data on HIV epidemic in the European Region

The European Centre for Disease Prevention and Control and the WHO Regional Office for Europe release the latest data on the HIV epidemic in the European Region, marking the 30th anniversary of World AIDS Day.

29 Nov 2018

HIV epidemic raging across Europe finds report

A new report has found that there is an HIV epidemic across Europe especially in Eastern Europe. The new diagnoses rose in 2017 the report said but the speed of rise has slowed.

28 Nov 2018

Study reveals direct link between stigma and cognitive performance in people with HIV

A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.

27 Nov 2018

BIO issues statement on proposed changes to Medicare Part D and Medicare Advantage plans

BIO President and CEO Jim Greenwood issued the following statement regarding today's proposed changes to Medicare Part D and Medicare Advantage plans.

26 Nov 2018

Scripps Research scientists reveal potential new approach to design HIV vaccines

A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.

26 Nov 2018

Researchers attempt to create world's first genetically edited babies

The researchers have used CRISPR to edit the genes of IVF embryos in a controversial attempt to create offspring that are resistant to disease.

26 Nov 2018

Breakthrough Alzheimer's discovery

A new study has found that the neurons in the brain can alter their genetic make-up unlike other cells of the body which remain constant.

22 Nov 2018

Myriad biological, societal factors that impact CKD severity for children of African descent

Myriad biological and societal factors can impact the occurrence and accelerate progression of chronic kidney disease for children of African descent - including preterm birth, exposure to toxins during gestation and lower socioeconomic status - and can complicate these children's access to effective treatments, according to an invited commentary published in the November 2018 edition of American Journal of Kidney Diseases.

21 Nov 2018

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can "neutralize" the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States.

21 Nov 2018

First modeling system developed for testing age-specific human immune responses to vaccines

A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines -- outside the body. The practical, cost-effective new platform, using all human components, is expected to accelerate and de-risk the development, assessment and selection of vaccines.

20 Nov 2018

Routine HCV testing in correctional facilities can best identify and treat disease, say researchers

Results from a new study led by Boston Medical Center (BMC) found routine Hepatitis C testing identified a significant number of cases that would have been missed by targeted testing among a population of individuals in Washington State prisons.

20 Nov 2018

AHF commends the passage of global AIDS funding in the House, calls for swift approval

AIDS Healthcare Foundation (AHF) today praised the U.S. House of Representatives for unanimously approving H.R. 6651, the PEPFAR Extension Act of 2018 (H.R. 6651) on November 13.

20 Nov 2018

Individuals identified as lesbian, gay more likely to misuse opioids than heterosexual

Men and women who identify as lesbian, gay, or bisexual are more likely to misuse opioids when compared with those who identify as heterosexual, a new study shows.

19 Nov 2018

Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure

A majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy originated from cellular proliferation, not viral replication, according to new research published in Nature Communications.

17 Nov 2018

Mechanisms that govern HIV latency differ in the gut and blood, finds study

Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical Center and the University of California, San Francisco, and colleagues.

16 Nov 2018

An underused strategy for surge in STDs: Treat patients’ partners without a doctor visit

If patients return to Dr. Crystal Bowe soon after taking medication for a sexually transmitted infection, she usually knows the reason: Their partners have re-infected them.

13 Nov 2018

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

A phase 2 clinical trial led by Stephanie N. Taylor, MD, Professor of Medicine and Microbiology in the Section of Infectious Diseases at LSU Health New Orleans School of Medicine, has found that a new antibiotic effectively treats uncomplicated urogenital and rectal gonorrhea infections in a single oral dose.

9 Nov 2018

Monash researchers provide insight into intricate peptide changes affecting immune system

Human leukocyte antigen molecules are a group of proteins that help the immune system identify foreign invaders such as viruses and bacteria and which impact a wide variety of clinical outcomes including infection and cancer.

8 Nov 2018

Oral antibiotic shows promise to cure uncomplicated gonorrhea

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine.

8 Nov 2018

HIV-2 is more pathogenic than previously demonstrated, finds study

A study published in The Lancet HIV shows that HIV-2 is more pathogenic than previously demonstrated. The new findings indicate that early treatment should be applied to all patients with HIV, not only to those with HIV-1.

7 Nov 2018

HIV 1 News and Research

ECDC and WHO release latest data on HIV epidemic in the European Region

HIV epidemic raging across Europe finds report

Study reveals direct link between stigma and cognitive performance in people with HIV

BIO issues statement on proposed changes to Medicare Part D and Medicare Advantage plans

Scripps Research scientists reveal potential new approach to design HIV vaccines

Researchers attempt to create world's first genetically edited babies

Breakthrough Alzheimer's discovery

Myriad biological, societal factors that impact CKD severity for children of African descent

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

First modeling system developed for testing age-specific human immune responses to vaccines

Routine HCV testing in correctional facilities can best identify and treat disease, say researchers

AHF commends the passage of global AIDS funding in the House, calls for swift approval

Individuals identified as lesbian, gay more likely to misuse opioids than heterosexual

Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure

Mechanisms that govern HIV latency differ in the gut and blood, finds study

An underused strategy for surge in STDs: Treat patients’ partners without a doctor visit

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

Monash researchers provide insight into intricate peptide changes affecting immune system

Oral antibiotic shows promise to cure uncomplicated gonorrhea

HIV-2 is more pathogenic than previously demonstrated, finds study

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News